ESC 365 - Effect of sacubitril/valsartan on cardiac remodeling compared with other renin-angiotensin-system inhibitors: a difference-in-difference analysis of propensity score matched samples

HFA Premium Access

Effect of sacubitril/valsartan on cardiac remodeling compared with other renin-angiotensin-system inhibitors: a difference-in-difference analysis of propensity score matched samples

Session: Chronic heart failure - pathophysiology and mechanisms 1

Topic: Ventricular Remodelling

Speaker: Doctor S. Sforna (Perugia, IT)

Event: Heart Failure 2023

Congress Presentation

Add to my library

About the speaker

Doctor Stefano Sforna

University of Perugia, Perugia (Italy)

0 follower

7 more presentations in this session

Right ventricular function and coupling to the pulmonary circulation in heart failure with preserved ejection fraction: the PARAGON-HF trial

Speaker: Doctor R. Inciardi (Brescia, IT)

Achieved heart rate of less than 70 beats per minute after ivabradine treatment is related to left ventricular reverse remodeling in idiopathic dilated cardiomyopathy

Speaker: Ms J. Lee (Seoul, KR)

Role of aldosterone in long-term left ventricular remodelling after acute myocardial infarction: the REMI study

Speaker: Doctor L. Monzo (Vandoeuvre-Les-Nancy, FR)

Cardiac reverse remodeling in real life, a therapeuthic objective.

Speaker: Miss C. Otte Alba (Sevilla, ES)

Contemporary use of SGLT2i therapy among patients hospitalized for heart failure with reduced ejection fraction in the United States

Speaker: Doctor S. Greene (Durham, US)

Access the full session

Chronic heart failure - pathophysiology and mechanisms 1

Speakers: Doctor S. Sforna, Doctor R. Inciardi, Ms J. Lee, Doctor L. Monzo, Miss C. Otte Alba...

About the event

Heart Failure 2023

20 May - 23 May 2023

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources